https://www.berndailypress.com/article/906126854-txone-networks-achieves-cybersecurity-certification-with-sgs Bern Daily Press en PressRelease 2026-04-16T15:54:19+00:00 TXOne Networks achieves cybersecurity certification with SGS https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24834447-2886-txone-1728x1012.jpeg https://www.berndailypress.com/article/906078423-maintmaster-verzeichnet-starke-nachfrage-nach-ki-f-r-industrielle-instandhaltung-und-produktion Bern Daily Press en PressRelease 2026-04-16T10:18:06+00:00 Maintmaster verzeichnet starke Nachfrage nach KI für industrielle Instandhaltung und Produktion https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23951193-maintmaster-manufacturing-intel-1200x628.png https://www.berndailypress.com/article/906181797-sportradar-to-release-first-quarter-2026-financial-and-operating-results-on-may-6-2026 Bern Daily Press en PressRelease 2026-04-16T20:52:02+00:00 Sportradar to Release First Quarter 2026 Financial and Operating Results on May 6, 2026 https://ml.globenewswire.com/media/5c0ef7f3-c5bb-4387-89f9-7a573869de56/small/sportradar-logo2-jpg.jpg https://www.berndailypress.com/article/906101366-helsinn-appoints-giacomo-braglia-to-the-board-of-directors Bern Daily Press en PressRelease 2026-04-16T12:00:00+00:00 Helsinn appoints Giacomo Braglia to the Board of Directors https://ml-eu.globenewswire.com/media/5159c168-3b3f-444e-bbee-456218d74062/small/helsinn-logo-h-helsinn-blue-and-grey-1-png.png https://www.berndailypress.com/article/906101650-biomedvc-adds-three-renowned-entrepreneurs-as-advisors-for-fund-iv-to-champion-early-stage-european-biotech Bern Daily Press en PressRelease 2026-04-16T10:29:56+00:00 BiomedVC Adds Three Renowned Entrepreneurs as Advisors for Fund IV to Champion Early-Stage European Biotech https://ml-eu.globenewswire.com/media/525d004d-96ab-45c1-85c0-605b470edd68/small/bmvc-logo-black-rgb-png.png https://www.berndailypress.com/article/906040574-bioversys-announces-first-patient-first-visit-in-habp-vabp-pivotal-phase-3-riv-target-trial-of-bv100 Bern Daily Press en PressRelease 2026-04-16T05:00:00+00:00 BioVersys Announces First Patient First Visit in HABP/VABP Pivotal Phase 3 RIV-TARGET Trial of BV100 https://ml.globenewswire.com/media/37dee549-5eb0-418f-a16c-11d8422babfb/small/logo-bioversys-color-rgb-neu-for-prs-jpg.jpg https://www.berndailypress.com/article/905930843-basilea-aktion-re-genehmigen-an-der-generalversammlung-2026-alle-antr-ge-des-verwaltungsrats Bern Daily Press en PressRelease 2026-04-15T16:30:00+00:00 Basilea-Aktionäre genehmigen an der Generalversammlung 2026 alle Anträge des Verwaltungsrats https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.berndailypress.com/article/905931077-basilea-shareholders-approve-all-proposals-of-the-board-of-directors-at-the-2026-annual-general-meeting Bern Daily Press en PressRelease 2026-04-15T16:30:00+00:00 Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting https://ml-eu.globenewswire.com/media/4403c5ae-6c9a-43d2-8c5f-deb2de747a47/small/basilea-logo-jpg.jpg https://www.berndailypress.com/article/905913948-what-if-you-could-reboot-sick-cells Bern Daily Press en PressRelease 2026-04-15T15:00:00+00:00 What if you could reboot sick cells? https://ml-eu.globenewswire.com/media/e93daf2c-fee9-4db8-8c09-bab3a01da23b/medium/targeted-mitochondrial-delivery.jpg